Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024523 (
malabsorption
)
7,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carnitine
CAR
) plays an important role in the beta-oxidation of fatty acids. Less attention. however, has been paid to
CAR
compared to other nutrients even in total parenteral nutrition (TPN). To examine
CAR
metabolism during TPN and the effect of simultaneous oral L-
CAR
supplementation on
CAR
levels, the blood
CAR
level was measured in a 3-year-old boy receiving long-term TPN because of short bowel syndrome. Both the total and acyl
CAR
in the serum were evaluated under various nutritional conditions including oral supplementation of L-
CAR
. Low
CAR
concentrations were observed especially when lipid containing TPN regimens were in place. Oral L-
CAR
supplementation was not sufficient to restore the low
CAR
levels in the present index patient even when the dose was increased to 120 mg/kg in accordance with the result of the L-
CAR
absorption test that revealed poor intestinal absorption of this nutrient. Moreover, a markedly low
CAR
level was measured during the onset of sepsis in the patient, and the blood
CAR
was depleted when lipid metabolism was activated by lipid loading or sepsis. To date, the late effects of
CAR
depletion on child growth have not been well examined. It is recommended that the blood
CAR
level be maintained at normal levels before any prominent manifestations of the deficiency have developed. The intravenous administration of
CAR
appears to be necessary to supply a sufficient amount of
CAR
for patients with severe
malabsorption
.
...
PMID:Carnitine depletion during total parenteral nutrition despite oral L-carnitine supplementation. 914 Dec 53
There is increasing evidence that the magnitude and potential of intestinal nutrient absorption (sugars, fatty acids, cholesterol and triglycerides) and intestinal defense function are regulated by metabolic learning phenomena, and are influenced by dietary energy content and exercise. Metabolic overload syndromes, mainly obesity, and chronic
malabsorption
disorders such as inflammatory bowel disease and celiac disease have been defined as extreme phenotypes. Metabolic learning processes depend on developmental and transcriptional control systems of intestinal epithelial cell differentiation. The physiological differentiation zone of enterocytes is linked to the beta-catenin system, apolipoprotein apoA-IV and the master transcription factors Cdx2, HNF1alpha, and GATA4. In addition to these developmental regulatory transcription factors, nuclear receptors including RXR, LXR, PPAR, PXR, and
CAR
have been implicated in the generation of more absorptive enterocytes with a more differentiated phenotype on the one hand, and dedifferentiated cells with reduced capacity of detoxification and defense causing loss of junction control and barrier defects on the other. Large-scale analysis of gene expression profiles and identification of key pathways and master regulatory transcription factors will help dissect the role of nutritional and environmental factors as well as pharmacological intervention on mucosal homeostasis and disease, with potential applications for diagnosis and therapy.
...
PMID:Metabolic learning in the intestine: adaptation to nutrition and luminal factors. 1693 81